Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
TAMPA, Fla., Feb. 1 /PRNewswire/ Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain. (Logo: )The clinical trial is being conducted in approximately 25 sites across the United States and is expected [...]